• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Division of Medical Imaging Products (DMIP)


Liberto (Louis) Marzella, M.D., Ph.D., Director
Alex Gorovets, M.D., (Acting) Deputy Director
Ira Krefting, M.D.Deputy Director for Safety
Kyong "Kaye" Kang, Pharm.D., Chief, Project Management Staff
Crystal Coulter, Program Specialist - Program Management and Analysis Staff
Kim Ritenour-Miller, Technical Information Specialist


The Division of Medical Imaging Products (DMIP) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs), and Biologic Licensing Applications (BLAs) for small molecule agents and biologics used in medical imaging.

  • The medical imaging products include contrast agents and radiolabeled pharmaceuticals used for diagnostic purposes. The imaging products also include decorporation agents used to treat individuals exposed to particulate radioactive materials.

Mailing Address:

Food and Drug Administration

Center for Drug Evaluation and Research

Division of Medical Imaging Products

5901-B Ammendale Road

Beltsville, MD 20705-1266

Phone: (301) 796-2050
Fax: (301) 796-9848